Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study – The Lancet

The effective control of COVID-19 in Australia appears to have mitigated the initialimpact of COVID-19 on systemic cancer therapy….

Published

4 years ago

August 4, 2021

[1].Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China.
JAMA.2020; 323: 1061-1069

[2].SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
JAMA oncology.2020;…

Related Topics:Australia The Lancet

A machine learning approach for predicting risk of schizophrenia using a blood test – Baylor College of Medicine News

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net

Coomalie council dismissed by NT government after investigation finds ‘serious deficiencies’

Huge suburban crowd cheers for luxury house sale at sausage sizzle auction

Trump’s trade war puts Australian beef centre stage in Shanghai

Grain growers face costly nightmare of ‘clumped’ fertiliser

Noosa Online News